Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)( | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  154542 of 156022  at  1/22/2021 1:20:19 PM  by

NewJeans


 In response to msg 154540 by  egomaniakos
view thread

Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021

Just about everything in the top half is a regulatory decision or pivotal readout. The one exception is SERD '859 proof of concept at the top, however that same agent also has a pivotal readout as a monotherapy. So I don't think one can take a shot at the other proof of concepts including ST400 and BIV003 for appearing at the bottom of the list. These proof of concepts should be at the bottom below the regulatory and pivotal readouts.
 
Also we already know beta-thal had an issue(s) not related to editing. It's possible a correction or improvement was implemented prior to one of more sickle cell subjects being dosed. So mixed results from ST400 and BIV003 would be very good news as we could look forward to the improvement being implemented in beta-thal too.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 15     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
154544 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 sangamo 2 1/22/2021 1:50:25 PM
154545 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 bct1192 23 1/22/2021 1:51:43 PM
154550 Re: Sanofi says ST400(**)(4) Proof of concept study read-out in Beta thalassemia H1 2021 BIVV003(**)(4) Proof of concept study read-out in Sickle Cell Disease H1 2021 rynotheknife 0 1/22/2021 2:29:48 PM








Financial Market Data provided by
.
Loading...